Suppr超能文献

澳大利亚前列腺癌死亡率、根治性前列腺切除术及前列腺特异性抗原检测的城乡差异

Urban-rural differences in prostate cancer mortality, radical prostatectomy and prostate-specific antigen testing in Australia.

作者信息

Coory Michael D, Baade Peter D

机构信息

Health Information Centre, Queensland Health, Brisbane, QLD.

出版信息

Med J Aust. 2005 Feb 7;182(3):112-5. doi: 10.5694/j.1326-5377.2005.tb06609.x.

Abstract

OBJECTIVE

To assess differences in trends for prostate cancer mortality, radical prostatectomy and prostate-specific antigen (PSA) testing for Australian men aged 50-79 years living in capital cities compared with regional and rural areas.

DESIGN

Descriptive, population-based study based on data from official sources from 1985 to the 2002/03 financial year (depending on data availability).

MAIN OUTCOME MEASURES

Age-standardised rates per 100,000 men aged 50-79 years of mortality from prostate cancer, incidence of prostate cancer, PSA tests and radical prostatectomy.

RESULTS

We found a statistically significant and increasing (age-standardised) mortality excess for prostate cancer in regional and rural areas. In 2000-2002 the excess (compared with capital cities) was 21% (95% CI, 14%-29%). Rates of radical prostatectomy in rural and regional Australia were 29% lower (95% CI, 23% lower to 35% lower) than in capital cities. Although PSA testing is common across the whole of Australia, age-standardised rates in 2002/03 were 16% lower (95% CI, 15% lower to 17% lower) in regional and rural areas than in capital cities.

CONCLUSIONS

Our results show that the probability of a man having a PSA test and the management of his prostate cancer depend on where he lives. The cause or causes of the prostate cancer mortality excess in regional/rural areas cannot be established in a descriptive study, but fewer radical prostatectomies in regional and rural areas, perhaps associated with less PSA screening, remain among the several competing hypotheses. Other possibilities are related to other differences in management, perhaps associated with access to urologists. Governments and other budget holders need good evidence about the effectiveness of prostate cancer screening and early treatment, but also about the best strategies for providing equitable access to cancer services in both urban and rural areas.

摘要

目的

评估居住在澳大利亚首都城市的50 - 79岁男性与地区及农村地区男性在前列腺癌死亡率、根治性前列腺切除术及前列腺特异性抗原(PSA)检测方面的趋势差异。

设计

基于1985年至2002/03财政年度官方来源数据(取决于数据可用性)的描述性、基于人群的研究。

主要观察指标

每10万名50 - 79岁男性的前列腺癌年龄标准化死亡率、前列腺癌发病率、PSA检测及根治性前列腺切除术。

结果

我们发现地区及农村地区前列腺癌(年龄标准化)死亡率存在统计学显著且不断上升的差异。在2000 - 2002年,(与首都城市相比)该差异为21%(95%可信区间,14% - 29%)。澳大利亚农村和地区的根治性前列腺切除术发生率比首都城市低29%(95%可信区间,低23%至低35%)。尽管PSA检测在澳大利亚全国都很普遍,但2002/03年地区及农村地区的年龄标准化率比首都城市低16%(95%可信区间,低15%至低17%)。

结论

我们的结果表明,男性进行PSA检测的可能性及其前列腺癌的治疗方式取决于其居住地点。在描述性研究中无法确定地区/农村地区前列腺癌死亡率过高的原因,但地区及农村地区根治性前列腺切除术较少,可能与PSA筛查较少有关,这仍是几种相互竞争的假设之一。其他可能性与治疗管理方面的其他差异有关,可能与泌尿科医生的可及性有关。政府和其他预算持有者需要关于前列腺癌筛查和早期治疗有效性的充分证据,也需要关于在城乡地区公平提供癌症服务的最佳策略的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验